Company: PSTV
Filing Date: 2025-08-04
Form Type: DRS
Source: 0000950123-25-006916
Chunk: 36

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-04
Form: DRS
Chunk 36
---
 discourage certain types

22

Confidential Treatment Requested by Plus Therapeutics, Inc. Pursuant to 17 C.F.R. Section 200.83 of coercive takeover practices and inadequate takeover bids. These provisions are also designed, in part, to encourage persons seeking to acquire control of us to first negotiate with our board of directors. Certificate of Incorporation and Bylaws. Our amended and restated certificate of incorporation, as amended, and amended and restated bylaws include provisions that:

| • |     | authorize the board of directors to issue, without stockholder approval, blank-check preferred stock with such                                                                                                                                           
 designations, powers, preferences and other rights and qualifications, limitations or restrictions as our board of directors may authorize, which preferred stock could decrease the amount of earnings and assets available for distribution to holders 
 of our common stock or adversely affect the rights and powers, including voting rights, of the holders of our common stock;                                                                                                                              |

| • |     | establish advance notice requirements for stockholder nominations of directors and for stockholder proposals that 
 can be acted on at stockholder meetings;                                                                          |

| • |     | limit who may call stockholder meetings; |

| • |     | require that any action to be taken by our stockholders be effected at a duly called annual or special meeting 
 and not by written consent;                                                                                    |

| • |     | provide that vacancies on our board of directors may be filled only by a majority of directors then in office, 
 even if less than a quorum; and                                                                                |

| • |     | authorize us to indemnify officers and directors against losses that they may incur in investigations and legal           
 proceedings resulting from their services to us, which may include services in connection with takeover defense measures. |

Delaware anti-takeover statute. We are subject to Section 203 of the DGCL, which prohibits persons deemed to be “interested stockholders” from engaging in a “business combination” with a publicly held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an “interested stockholder” is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation’s voting stock. Generally, a “business combination” includes a merger, asset or stock sale, or